Investment Rating - The report maintains a "Buy" rating for the company, anticipating a price increase of over 15% within the next 6-12 months [3][11]. Core Views - The company is expected to benefit first as the industry stabilizes, with future performance projected to return to a growth trajectory [3]. - The company has a strong market position, ranking second in contract sales within the industry, and maintains a significant market share in key cities [2][3]. Financial Performance - For the first half of 2025, the company reported revenue of 832.2 billion CNY, a year-on-year decrease of 4.5%, and a net profit attributable to shareholders of 86.0 billion CNY, down 16.6% year-on-year [1]. - The gross profit margin for the first half of 2025 was 17.4%, a decline of 4.7 percentage points compared to the previous year, yet still above industry averages [1]. - The company achieved a contract sales amount of 1201.5 billion CNY in the first half of 2025, representing a 19% decrease year-on-year [1]. Market Position and Strategy - The company focuses on high-energy cities, with 86% of its land acquisitions in first-tier and strong second-tier cities [2]. - As of the end of July 2025, the company had acquired 22 plots of land with a total investment of 550.1 billion CNY, leading the industry in investment scale [2]. Financial Health - The company's financial structure is described as safe and robust, with key financial metrics indicating a healthy balance sheet. The asset-liability ratio, excluding advance receipts, stands at 45.7%, and the net debt ratio is 28.4% [2]. - The average financing cost for the first half of 2025 was 2.9%, which is the lowest in the industry, having decreased by 20 basis points from the end of 2024 [2]. Profit Forecast and Valuation - The projected net profit for the company from 2025 to 2027 is 133.9 billion CNY, 146.2 billion CNY, and 154.7 billion CNY, with year-on-year growth rates of -14.4%, +9.2%, and +5.8% respectively [3]. - The current stock price corresponds to a price-to-earnings (PE) ratio of 10.4x for 2025, 9.5x for 2026, and 9.0x for 2027 [3].

业绩简评 2025 年 8 月 27 日早晨，公司发布 2024 中期业绩：实现营收 85.2 亿元，同比+6.5%；归母净利润 20.3 亿元，同比+7.4%；核心净利 润 20.1 亿元，同比+15.0%。 经营分析 毛利率水平持续提升，两费费率下降，提质增效带动业绩高质量 增长。2024 年①收入同比+6.5%，其中商业航道同比+14.6%，物业 航道同比+1.1%。②毛利率：综合 37.1%，同比+3.1pct，其中商业 航道 66.1%，同比+5.2pct；物业航道 18.8%，同比-0.1pct。③两 费费率 6.3%，同比-0.6pct。 提升中期派息率并宣派特别股息，首次实现中期核心净利润 100% 分派。1H25 公司中期每股股息 0.529 元，同比+89.6%；同时宣派 特别股息每股 0.352 元。公司以股东价值最大化为导向，首次在 中期实现 100%核心净利润分派。 盈利预测、估值与评级 考虑到公司在商业航道持续领跑市场，构筑广阔壁垒，近年来购 物中心开业持续放量；在物业航道实现有质量的规模增长。我们 预计公司2025-2027年归母净利润分别为41.0亿元、45.0元、48.9 亿 ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [6]. Core Insights - The company reported a revenue of 880 million yuan for the first half of 2025, a year-on-year increase of 10.0%, with a net profit of 130 million yuan, up 0.4% year-on-year [2]. - The company is investing approximately 800 million yuan in a new robot intelligent control system production project, with a construction period of 24 months [2]. - The company is experiencing steady growth in its core business and has made significant progress in its internationalization strategy, particularly in the PLC and drive systems segments [3]. Summary by Sections Performance Review - In Q2 2025, the company achieved a revenue of 490 million yuan, a 6.9% year-on-year increase, with a net profit of 80 million yuan, down 1.3% year-on-year [2]. - The gross margin for Q2 was 38.4%, an increase of 0.3 percentage points year-on-year [2]. Business Operations - The PLC segment generated 310 million yuan in revenue for H1 2025, a 0.5% increase year-on-year, maintaining a leading market share in domestic small PLCs [3]. - The drive systems segment saw a revenue increase of 19% year-on-year, with stepper motors and variable frequency drive products achieving a 50% revenue growth [3]. - The company is focusing on large clients and expanding its international presence, with overseas orders increasing by nearly 50% year-on-year in H1 [3]. Emerging Industry Expansion - The company is accelerating its investment in humanoid robots, achieving small-scale sales of key components and collaborating with major robotics firms [4]. - The partnership with Huawei Cloud aims to develop advanced collaborative robots, indicating a strong potential for commercialization in the robotics sector [4]. Financial Projections - The company is expected to achieve net profits of 270 million yuan, 340 million yuan, and 400 million yuan for the years 2025, 2026, and 2027, respectively, with growth rates of 19%, 25%, and 19% [6]. - The current price corresponds to a P/E ratio of 34, 27, and 23 for the years 2025, 2026, and 2027 [6].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [4][12]. Core Viewpoints - The company reported a revenue of 1.798 billion yuan for the first half of 2025, representing an 8.80% year-on-year growth, and a net profit of 516 million yuan, which is a 17.19% increase year-on-year [1]. - The blood products business continues to grow steadily, with a revenue of 1.738 billion yuan, up 7.49% year-on-year, and a net profit of 501.89 million yuan, up 18.51% year-on-year [2]. - The company is actively enhancing its plasma collection capabilities, achieving a total plasma collection of 803.66 tons in the first half of 2025, a 5.23% increase compared to the same period last year [2]. - Revenue from similar drugs is on the rise, with the company's affiliate, Hualan Gene, generating sales of 59 million yuan from Bevacizumab [3]. - The company is advancing its innovative drug development, with several products in various stages of clinical trials [3]. Summary by Sections Performance Review - In the first half of 2025, the company achieved an operating income of 1.798 billion yuan, a year-on-year increase of 8.80%, and a net profit attributable to shareholders of 516 million yuan, up 17.19% year-on-year [1]. Operational Analysis - The blood products segment generated 1.738 billion yuan in revenue, a 7.49% increase year-on-year, with a net profit of 501.89 million yuan, reflecting an 18.51% growth [2]. - The company has successfully established a new plasma collection station in Fengdu County, Chongqing, contributing to a total plasma collection of 803.66 tons, a 5.23% increase year-on-year [2]. Profit Forecast, Valuation, and Rating - The report forecasts the company's net profit for 2025-2027 to be 1.25 billion yuan (+15%), 1.41 billion yuan (+13%), and 1.59 billion yuan (+13%) respectively, with corresponding EPS of 0.68, 0.77, and 0.87 yuan [4].

业绩简评 2025 年 8 月 26 日，公司发布 2025 年半年度报告。25H1 公司实现 营业收入 115.07 亿元（同比+9.12%），归母净利润 20.51 亿元（同 比+0.05%），扣非归母净利润 20.40 亿元（同比+14.30%）。 单季度来看，25Q2 公司实现收入 54.81 亿元（同比+2.47%），归母 净利润 10.01 亿元（同比-13.0%），扣非归母净利润 9.80 亿元（同 比+4.03%）。 经营分析 门诊及手术量稳步增长，屈光、视光业务引领增长。25H1 公司实 现门诊量 924.83 万人次（同比+16.47%），手术量 87.9 万例（同 比+7.63%）。分业务看，屈光项目通过技术升级有效"反内卷"，实 现收入 46.18 亿元（同比+11.14%），毛利率为 56.12%；视光服务 项目受益于"5P 近视防控模式"推广，收入达 27.20 亿元（同比 +14.73%），毛利率为 54.21%；白内障项目在医保支付改革背景下， 通过推广屈光性白内障手术实现收入 17.81 亿元（同比+2.64%）， 毛利率为 36.34%；眼前段项目收入 10.31 亿元（同 ...

业绩简评 2025 年 8 月 26 日公司披露半年报，上半年实现营收 56.63 亿元， 同比增长 41.2%。实现归母净利润 16.25 亿元，同比增长 121.5%。 实现经调整净利润 10.86 亿元，同比增长 42.4%。实现经调整核心 利润 11.36 亿元，同比增长 49.0%。 经营分析 盈利预测、估值与评级 受益于平台外卖促销活动，我们上调公司盈利预测，预计公司 FY2025/FY2026/FY2027 年 经 调 整 净 利 润 分 别 为 21.96/ 26.16/31.48 亿元，对应经调整 PE 分别 23/20/16 倍。维持"买入" 评级。 风险提示 行业竞争加剧风险；餐饮消费不及预期风险；外卖补贴退坡影响； 食品安全风险；拓店不及预期风险。 0 200 400 600 800 1,000 1,200 1,400 1,600 8.00 12.00 16.00 20.00 24.00 28.00 32.00 250212 250512 250812 港币(元) 成交金额(百万元) 成交金额 古茗 恒生指数 | 主要财务指标 | | | | | | | --- | --- | --- ...

Investment Rating - The report maintains a "Buy" rating for the company, with expected EPS for 2025-2027 at 1.86, 2.12, and 2.43 RMB respectively, corresponding to PE ratios of 13, 12, and 10 times [6]. Core Viewpoints - The company has shown steady revenue growth in H1 2025, with a revenue increase of 7.10% year-on-year, and a net profit increase of 11.42% [2]. - The recovery of downstream demand is expected to support stable revenue growth, particularly in eco-friendly packaging, which is anticipated to continue expanding [3]. - The company has implemented a new equity incentive plan, reflecting confidence in long-term development and a clear path for valuation uplift [5]. Performance Summary - In H1 2025, the company reported revenues of 7.876 billion RMB and a net profit of 554 million RMB, with a proposed cash dividend of 0.43 RMB per share, resulting in a payout ratio of 70.18% [2]. - The revenue from paper-based premium packaging, packaging supporting products, and eco-friendly paper-plastic products was 5.461 billion RMB, 1.297 billion RMB, and 584 million RMB respectively, with year-on-year growth rates of 5.39%, -6.70%, and 6.77% [3]. - The gross margin for H1 2025 was 22.77%, with a net margin of 6.80%, showing slight declines compared to the previous year [4]. Financial Projections - The company is projected to achieve revenues of 19.002 billion RMB in 2025, with a growth rate of 10.75% [11]. - The diluted EPS is expected to grow from 1.864 RMB in 2025 to 2.425 RMB in 2027, indicating a positive growth trajectory [11]. - The company’s return on equity (ROE) is projected to be 14.10% in 2025, with a P/E ratio of 13.24 [11].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5][11]. Core Insights - The company reported a revenue of 6.435 billion RMB for the first half of 2025, a year-on-year decrease of 4.87%, and a net profit attributable to shareholders of 181 million RMB, down 39.58% year-on-year. The second quarter showed a revenue of 3.441 billion RMB, a quarter-on-quarter increase of 14.93%, and a net profit of 91.1 million RMB, up 1.51% quarter-on-quarter, aligning with expectations [2]. - The company is focusing on rapid iteration in the photovoltaic paste product development to meet customer demands, achieving significant breakthroughs in various metallization technologies, which have led to a cumulative efficiency gain of 0.2% for the year [3]. - The company is extending its industrial chain and expanding its product matrix, with its subsidiary achieving mass production in non-photovoltaic silver paste fields and developing new generation encapsulation adhesives for photovoltaic modules [4]. Summary by Sections Performance Review - In the first half of 2025, the company achieved a revenue of 6.435 billion RMB, down 4.87% year-on-year, and a net profit of 181 million RMB, down 39.58% year-on-year. The second quarter saw a revenue of 3.441 billion RMB, up 14.93% quarter-on-quarter, and a net profit of 91.1 million RMB, up 1.51% quarter-on-quarter, meeting expectations [2]. Operational Analysis - The industry is experiencing an upward turning point, with a significant reduction in credit impairment provisions. The company's cash flow from operating activities in the second quarter was -979 million RMB, a decrease of 722.69% quarter-on-quarter. The company recorded an impairment loss of 39 million RMB in the second quarter, indicating potential recovery in cash flow and impairment situations as the photovoltaic industry continues to improve [2]. Product Development - The company has established a comprehensive technology matrix in the photovoltaic conductive paste field, achieving breakthroughs in high-performance silver paste and UV-resistant silver paste technologies, contributing to a significant reduction in battery costs [3]. Industry Chain Expansion - The company is expanding its product offerings beyond photovoltaic silver paste, with its subsidiary achieving mass production in various electronic paste products and developing advanced encapsulation adhesives for photovoltaic modules, addressing industry pain points [4]. Profit Forecast and Valuation - The profit forecasts for 2025-2027 are adjusted to 411 million RMB, 506 million RMB, and 604 million RMB, respectively, with corresponding EPS of 1.70, 2.09, and 2.50 RMB. The current stock price corresponds to PE ratios of 31, 25, and 21 times [5].

Investment Rating - The report maintains a "Buy" rating for the company, with a projected price-to-earnings (PE) ratio of 31/25/20x for the years 2025-2027 [4]. Core Insights - The company achieved a revenue of 32.96 billion yuan in the first half of 2025, representing a year-on-year growth of 14.2%, and a net profit attributable to shareholders of 1.14 billion yuan, up 32.7% year-on-year [2]. - The consumer electronics segment generated revenue of 27.185 billion yuan in the first half of 2025, with a gross margin of 13.2%, slightly down by 0.56 percentage points year-on-year [3]. - The smart automotive and cockpit segment reported revenue of 3.165 billion yuan, a year-on-year increase of 16.45%, with a gross margin of 9.84% [3]. - The smart headsets and wearables segment achieved revenue of 1.647 billion yuan, growing 14.74% year-on-year, with a gross margin of 23.3%, an increase of 9.7 percentage points [4]. Summary by Relevant Sections Performance Review - In Q2 2025, the company recorded revenue of 15.9 billion yuan, a year-on-year increase of 18.9%, but a quarter-on-quarter decrease of 6.8%. The net profit for Q2 was 710 million yuan, up 29.3% year-on-year and 66.4% quarter-on-quarter [2]. Business Analysis - The consumer electronics business continues to solidify its market position, with significant growth in high-end mobile phone components and a recovery in personal computer sales [3]. - The smart automotive sector is expanding with successful product launches and collaborations with leading automotive brands, indicating a strong growth trajectory [3]. Profit Forecast and Valuation - The forecast for net profit attributable to shareholders is 5.175 billion yuan for 2025, with expected growth rates of 42.81% in 2025, 24.17% in 2026, and 25.35% in 2027 [4][8].

Investment Rating - The report maintains a "Buy" rating for the company, with expected net profits of 1.4 billion, 1.6 billion, and 1.7 billion RMB for 2025-2027, corresponding to PE valuations of 12, 11, and 10 times respectively [2] Core Insights - The company reported a revenue of 9.39 billion RMB for the first half of 2025, a year-on-year increase of 6.18%, with a notable improvement in Q2, achieving a revenue of 5.12 billion RMB, up 9.89% year-on-year [1] - The overseas market continues to drive strong growth, with overseas revenue reaching 4.02 billion RMB in the first half of 2025, a 15.20% increase year-on-year, accounting for 43% of total revenue, a historical high [1] - The company's gross margin improved to 23.58% in the first half of 2025, up 0.36 percentage points year-on-year, with Q2 gross margin at 24.64%, reflecting product structure optimization and increased high-margin overseas business [1] - The intelligent logistics business has become a significant growth driver, with revenue growth of 59.1% year-on-year in the first half of 2025, indicating a strategic expansion into the robotics sector [1] Summary by Sections Performance Review - The company achieved a net profit of 796 million RMB in the first half of 2025, down 4.60% year-on-year, but Q2 net profit improved to 474 million RMB, up 9.8% year-on-year [1] Operational Analysis - The company sold 204,200 units in the first half of 2025, a 17.23% increase year-on-year, with domestic sales at 126,200 units (up 11.28%) and overseas sales at 73,600 units (up 23.08%) [1] - The company is developing a manufacturing base in Thailand to enhance its global manufacturing footprint [1] Profitability and Cash Flow - The net profit margin for the first half of 2025 was 9.6%, with a Q2 margin of 10.5%, reflecting improved operational efficiency [1] - Operating cash flow for the first half of 2025 was 589 million RMB, an increase of 81.81% year-on-year, indicating enhanced cash collection capabilities [1] Future Outlook - The company is expected to continue its growth trajectory, with projected revenues of 18.68 billion RMB in 2025, reflecting a growth rate of 7.84% [7]